Organon & Co.
OGN
$10.38
$0.707.23%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.59B | 1.51B | 1.59B | 1.58B | 1.61B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.59B | 1.51B | 1.59B | 1.58B | 1.61B |
| Cost of Revenue | 710.00M | 663.00M | 696.00M | 659.00M | 668.00M |
| Gross Profit | 884.00M | 850.00M | 896.00M | 923.00M | 939.00M |
| SG&A Expenses | 453.00M | 420.00M | 468.00M | 422.00M | 437.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.26B | 1.18B | 1.29B | 1.19B | 1.22B |
| Operating Income | 336.00M | 334.00M | 298.00M | 390.00M | 386.00M |
| Income Before Tax | 229.00M | 101.00M | 129.00M | 207.00M | 235.00M |
| Income Tax Expenses | 84.00M | 14.00M | 20.00M | -152.00M | 40.00M |
| Earnings from Continuing Operations | 145.00M | 87.00M | 109.00M | 359.00M | 195.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 145.00M | 87.00M | 109.00M | 359.00M | 195.00M |
| EBIT | 336.00M | 334.00M | 298.00M | 390.00M | 386.00M |
| EBITDA | 425.00M | 418.00M | 375.00M | 459.00M | 452.00M |
| EPS Basic | 0.56 | 0.34 | 0.42 | 1.39 | 0.76 |
| Normalized Basic EPS | 0.47 | 0.52 | 0.36 | 0.63 | 0.61 |
| EPS Diluted | 0.56 | 0.33 | 0.41 | 1.38 | 0.75 |
| Normalized Diluted EPS | 0.47 | 0.51 | 0.36 | 0.62 | 0.60 |
| Average Basic Shares Outstanding | 259.94M | 257.86M | 257.69M | 257.50M | 257.29M |
| Average Diluted Shares Outstanding | 260.16M | 261.00M | 259.88M | 259.76M | 258.60M |
| Dividend Per Share | 0.02 | 0.28 | 0.28 | 0.28 | 0.28 |
| Payout Ratio | 6.90% | 81.61% | 67.89% | 20.61% | 40.51% |